LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability
Autoři:
Jiao-Xiang Wu aff001; Kun-Yan He aff002; Zhuang-Zhuang Zhang aff001; Yu-Lan Qu aff002; Xian-Bin Su aff002; Yi Shi aff002; Na Wang aff002; Lan Wang aff002; Ze-Guang Han aff001
Působiště autorů:
Key Laboratory of Systems Biomedicine (Ministry of Education) and Collaborative Innovation Center of Systems Biomedicine of Rui-Jin Hospital, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medici...
aff001; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China
aff002; Shanghai-MOST Key Laboratory for Disease and Health Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China
aff003
Vyšlo v časopise:
LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability. PLoS Genet 17(2): e1009357. doi:10.1371/journal.pgen.1009357
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pgen.1009357
Souhrn
The conserved zona pellucida (ZP) domain is found in hundreds of extracellular proteins that are expressed in various organs and play a variety of roles as structural components, receptors and tumor suppressors. A liver-specific zona pellucida domain-containing protein (LZP), also named OIT3, has been shown to be mainly expressed in human and mouse hepatocytes; however, the physiological function of LZP in the liver remains unclear. Here, we show that Lzp deletion inhibited very low-density lipoprotein (VLDL) secretion, leading to hepatic TG accumulation and lower serum TG levels in mice. The apolipoprotein B (apoB) levels were significantly decreased in the liver, serum, and VLDL particles of LZP-deficient mice. In the presence of LZP, which is localized to the endoplasmic reticulum (ER) and Golgi apparatus, the ER-associated degradation (ERAD) of apoB was attenuated; in contrast, in the absence of LZP, apoB was ubiquitinated by AMFR, a known E3 ubiquitin ligase specific for apoB, and was subsequently degraded, leading to lower hepatic apoB levels and inhibited VLDL secretion. Interestingly, hepatic LZP levels were elevated in mice challenged with a high-fat diet and humans with simple hepatic steatosis, suggesting that LZP contributes to the physiological regulation of hepatic TG homeostasis. In general, our data establish an essential role for LZP in hepatic TG transportation and VLDL secretion by preventing the AMFR-mediated ubiquitination and degradation of apoB and therefore provide insight into the molecular function of LZP in hepatic lipid metabolism.
Klíčová slova:
Lipid metabolism – Fatty liver – Hepatocytes – Mouse models – Protein secretion – Secretion – Ubiquitination – Lipoprotein secretion
Zdroje
1. Plaza S, Chanut-Delalande H, Fernandes I, Wassarman PM, Payre F. From A to Z: apical structures and zona pellucida-domain proteins. Trends Cell Biol. 2010;20(9):524–32. doi: 10.1016/j.tcb.2010.06.002 20598543
2. Jovine L, Darie CC, Litscher ES, Wassarman PM. Zona pellucida domain proteins. Annu Rev Biochem. 2005;74:83–114. doi: 10.1146/annurev.biochem.74.082803.133039 15952882
3. Bokhove M, Jovine L. Structure of Zona Pellucida Module Proteins. Curr Top Dev Biol. 2018;130:413–42. doi: 10.1016/bs.ctdb.2018.02.007 29853186
4. Wilburn DB, Swanson WJ. The "ZP domain" is not one, but likely two independent domains. Mol Reprod Dev. 2017;84(4):284–5. doi: 10.1002/mrd.22781 28176401
5. Jovine L, Qi H, Williams Z, Litscher E, Wassarman PM. The ZP domain is a conserved module for polymerization of extracellular proteins. Nat Cell Biol. 2002;4(6):457–61. doi: 10.1038/ncb802 12021773
6. Xu ZG, Du JJ, Cui SJ, Wang ZQ, Huo KK, Li YY, et al. Identification of LZP gene from Mus musculus and Rattus norvegicus coding for a novel liver-specific ZP domain-containing secretory protein. DNA Seq. 2004;15(2):81–7. doi: 10.1080/10425170310001652200 15346761
7. Xu ZG, Du JJ, Zhang X, Cheng ZH, Ma ZZ, Xiao HS, et al. A novel liver-specific zona pellucida domain containing protein that is expressed rarely in hepatocellular carcinoma. Hepatology. 2003;38(3):735–44. doi: 10.1053/jhep.2003.50340 12939600
8. Yang HR, Wu CQ, Zhao SY, Guo JH. Identification and characterization of D8C, a novel domain present in liver-specific LZP, uromodulin and glycoprotein 2, mutated in familial juvenile hyperuricaemic nephropathy. FEBS Lett. 2004;578(3):236–8. doi: 10.1016/j.febslet.2004.10.092 15589826
9. Shen HL, Xu ZG, Huang LY, Liu D, Lin DH, Cao JB, et al. Liver-specific ZP domain-containing protein(LZP) as a new partner of Tamm-Horsfall protein harbors on renal tubules. Mol Cell Biochem. 2009;321(1–2):73–83. doi: 10.1007/s11010-008-9921-3 18830570
10. Yan B, Zhang ZZ, Huang LY, Shen HL, Han ZG. OIT3 deficiency impairs uric acid reabsorption in renal tubule. FEBS Lett 2012;586(6):760–5. doi: 10.1016/j.febslet.2012.01.038 22306318
11. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32. doi: 10.1002/hep.23594 20432259
12. Samuel VT, Shulman GI. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab. 2018;27(1):22–41. doi: 10.1016/j.cmet.2017.08.002 28867301
13. Gross B, Pawlak M, Lefebvre P, Staels B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2017;13(1):36–49. doi: 10.1038/nrendo.2016.135 27636730
14. Pajukanta AJLP. A treasure trove for lipoprotein biology. Nat Genet. 2008;40:2. doi: 10.1038/ng0208-129 18227868
15. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332(6037):1519–23. doi: 10.1126/science.1204265 21700865
16. Walther TC, Chung J, Farese RV Jr. Lipid Droplet Biogenesis. Annu Rev Cell Dev Biol. 2017;33:491–510. doi: 10.1146/annurev-cellbio-100616-060608 28793795
17. Sundaram M, Yao Z. Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion. Nutrition & Metabolism. 2010;7(1):35. doi: 10.1186/1743-7075-7-35 20423497
18. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production. and clearance Journal of Clinical Investigation. 1999;104(8):1087–96. doi: 10.1172/JCI6572 10525047
19. Ason B, Castro-Perez J, Tep S, Stefanni A, Tadin-Strapps M, Roddy T, et al. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5(Fatp5). Lipids. 2011;46(11):991–1003. doi: 10.1007/s11745-011-3596-3 21826528
20. Borensztajn J, Rone MS, Kotlar TJ. The inhibition in vivo of lipoprotein lipase(clearing-factor lipase) activity by triton WR-1339. Biochem J. 1976;156(3):539–43. doi: 10.1042/bj1560539 949335
21. Banaszak LJ, Ranatunga WK. The assembly of apoB-containing lipoproteins: a structural biology point of view. Ann Med. 2008;40(4):253–67. doi: 10.1080/07853890701813070 18428019
22. Gething M. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol. 1999;10(5):465–72. doi: 10.1006/scdb.1999.0318 10597629
23. Li J, Ni M, Lee B, Barron E, Hinton DR, Lee AS. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death. Differentiation. 2008;15(9):1460–71.
24. Liu Y, Conlon DM, Bi X, Slovik KJ, Shi J, Edelstein HI, et al. Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress. Cell Rep. 2017;19(7):1456–66. doi: 10.1016/j.celrep.2017.04.064 28514664
25. Ye J, Li JZ, Liu Y, Li X, Yang T, Ma X, et al. Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab. 2009;9(2):177–90. doi: 10.1016/j.cmet.2008.12.013 19187774
26. Vembar SS, Brodsky JL. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol. 2008;9(12):944–57. doi: 10.1038/nrm2546 19002207
27. Jun-shan Liang TK, Shengyun Fang, Junji Yamaguchi‡, Allan M. Weissman, Edward A. Fisher¶, and Henry N. Ginsberg. Overexpression of the Tumor Autocrine Motility Factor Receptor Gp78, a Ubiquitin Protein Ligase, Results in Increased Ubiquitinylation and Decreased Secretion of Apolipoprotein B100 in HepG2 Cells. Journal of Biological Chemistry. 2003;278, No. 26(Issue of June 27):23984–8.
28. Wang Q, Shinkre BA, Lee J, Weniger MA, Liu Y, Chen W, et al. The ERAD Inhibitor Eeyarestatin I Is a Bifunctional Compound with a Membrane-Binding Domain and a p97/VCP Inhibitory Group. PLoS One. 2010;5(11). doi: 10.1371/journal.pone.0015479 21124757
29. Sliz E, Sebert S, Wurtz P, Kangas AJ, Soininen P, Lehtimaki T, et al. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum Mol Genet. 2018;27(12):2214–23. doi: 10.1093/hmg/ddy124 29648650
30. Fisher E, Lake E, McLeod RS. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. J Biomed Res. 2014;28(3):178–93. doi: 10.7555/JBR.28.20140019 25013401
31. Shin J, Hernandezono A, Fedotova T, Ostlund C, Lee MJ, Gibeley S, et al. Nuclear envelope-localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis. Journal of Clinical Investigation. 2019. doi: 10.1172/JCI129769 31408437
32. Smagris E, Gilyard S, Basuray S, Cohen JC, Hobbs HH. Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins. J Biol Chem. 2016;291(20):10659–76. doi: 10.1074/jbc.M116.719955 27013658
33. BasuRay S, Wang Y, Smagris E, Cohen JC, Hobbs HH. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis. Proc Natl Acad Sci U S A. 2019;116(19):9521–6. doi: 10.1073/pnas.1901974116 31019090
34. Asp L, Magnusson B, Rutberg M, Li L, Boren J, Olofsson SO. Role of ADP ribosylation factor 1 in the assembly and secretion of ApoB-100-containing lipoproteins. Arterioscler Thromb Vasc Biol. 2005;25(3):566–70. doi: 10.1161/01.ATV.0000154135.21689.47 15618550
35. Aspichueta P, Perez-Agote B, Perez S, Ochoa B, Fresnedo O. Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver. J Endotoxin Res. 2006;12(3):181–92. doi: 10.1179/096805106X102174 16719989
36. Millar JS, Reyes-Soffer G, Jumes P, Dunbar RL, deGoma EM, Baer AL, et al. Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects. J Clin Invest. 2015;125(6):2510–22. doi: 10.1172/JCI80025 25961461
Článek vyšel v časopise
PLOS Genetics
2021 Číslo 2
- Prof. Libor Grubhoffer: Nová varianta mpox je příležitostí pokročit v poznání původce varioly
- Co obsahují nové pokyny WHO pro dozor nad antibiotickou rezistencí?
- AI místo lékaře? Výzkum zkoumal ochotu Čechů konzultovat své zdraví s umělou inteligencí
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
Nejčtenější v tomto čísle
- Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles
- ATF3 downmodulates its new targets IFI6 and IFI27 to suppress the growth and migration of tongue squamous cell carcinoma cells
- Transcriptome-wide transmission disequilibrium analysis identifies novel risk genes for autism spectrum disorder
- Four families of folate-independent methionine synthases